SCHEMBL1611673

SCHEMBL1611673

CCCCCCc1cccc2cc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.50
TLR8 Q9NR97 7/20 0.49
MAPT P10636 2/20 0.48
KCNH2 Q12809 1/20 0.46
MTNR1A P48039 2/20 0.45
BID P55957 3/20 0.43
MCL1 Q07820 3/20 0.43
BCL2L1 Q07817 2/20 0.43
BAK1 Q16611 2/20 0.43
KAT8 Q9H7Z6 2/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
EP300 Q09472 1/20 0.43
KAT2A Q92830 1/20 0.43
KAT2B Q92831 1/20 0.43
KAT5 Q92993 1/20 0.43
SAE1 Q9UBE0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27774569 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL27831196 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL1610855 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL11599518 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL9394658 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL1612051 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL9228217 1.00 LIPG (0.50) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL27615338 0.98 LIPG (0.49) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL17998807 0.98 LIPG (0.49) LIPGTLR8MAPTKCNH2MTNR1A
SCHEMBL27665199 0.98 LIPG (0.49) LIPGTLR8MAPTKCNH2MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020211572-A1 METHOD FOR SEPARATING 2-ALKYL ANTHRACENE AND USE OF 2-ALKYL ANTHRACENE IN PREPARATION OF HYDROGEN PEROXIDE 中国石油化工股份有限公司 2020-10-22 WO disclosed
CN-109704910-A The separation method of mixture containing anthracene alkylation reaction product 中国石油化工股份有限公司 2019-05-03 CN disclosed
US-20110087034-A1 Organic Semiconductor Material SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2011-04-14 US disclosed
EP-2248818-A1 ORGANIC SEMICONDUCTOR MATERIAL Sumitomo Chemical Company, Limited (JP) 2010-11-10 EP disclosed
US-5910269-A GENERATES A LARGE SHEAR STRESS AND LOW CURRENT DENSITY, EXHIBITS EXCELLENT WITHSTANDING DIELECTRIC BREAKDOWN STRENGTH, EXHIBITS EXCELLENT FLUIDITY AND REDISPERSABILITY IN THE ABSENCE OF AN ELECTRIC FIELD NIPPON SHOKUBAI CO., LTD. (JP) 1999-06-08 US disclosed
US-4255343-A HEATING ANTHRACENE AND A BRANCHED-CHAIN ALKYLATING AGENT USING AN ACID CATALYST; CATALYST SELECTIVITY E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110087034-A1 Organic Semiconductor Material OR10J3, TST, OR51E2 LIPG 4724/4885TLR8 4323/4885MAPT 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.